We perform automated and dynamic Excel-based forecasting models offering an easy-to-use valuation tool for multi-parameters scenarios analysis (Bionest Scenario Planning Tool™). Our models are fully tailored and integrate VBA programing.

  • Company Valuation : Drug discovery, specialty pharma, Medtech, diagnostics, healthcare services, etc…
  • Asset-based Valuation : Drug candidate, pipeline analysis, patent, know-how, medical technology, etc…

We used to provide valuation advisory in :

Transaction support

Licensing deal, partnerships, IP divestment/acquisition

Fairness Opinion

Financing round, spin-out strategies, IPO preparation, etc…

Commercial strategies assessment

Product positioning, market access strategies, new market opportunity; often combined by KOL validation/secondary market research